HIVE Blockchain Technologies (HIVE) had the highest return in 2017 by a small-cap US stock, returning 3,413.7%.
| ASSET | YEAR | % RETURN |
|---|---|---|
HIVE Blockchain Technologies (HIVE) | 2017 | 3,413.74% |
TSS, Inc Common Stock (TSSI) | 2017 | 1,200% |
Gravity (GRVY) | 2017 | 801.72% |
XOMA (XOMA) | 2017 | 747.62% |
Cronos (CRON) | 2017 | 592.83% |
AnaptysBio (ANAB) | 2017 | 529.5% |
Village Farms International (VFF) | 2017 | 474.78% |
Palvella Therapeutics (PVLA) | 2017 | 447.1% |
Semler Scientific (SMLR) | 2017 | 429.8% |
Esperion Therapeutics (ESPR) | 2017 | 414.38% |
Nektar Therapeutics (NKTR) | 2017 | 378.53% |
Dynavax Technologies (DVAX) | 2017 | 367.5% |
Talos Energy (TALO) | 2017 | 322.29% |
Xunlei Ltd Adr (XNET) | 2017 | 298.7% |
Global Industrial (GIC) | 2017 | 281.26% |
Assembly Biosciences (ASMB) | 2017 | 276.93% |
BioLife Solutions (BLFS) | 2017 | 270.37% |
Pulse Biosciences (PLSE) | 2017 | 263.08% |
Avalo Therapeutics (AVTX) | 2017 | 259.55% |
Uniqure (QURE) | 2017 | 247.34% |
Galectin Therapeutics (GALT) | 2017 | 244.33% |
Canopy Growth (CGC) | 2017 | 243.74% |
Lendingtree (TREE) | 2017 | 230.86% |
Astrana Health (ASTH) | 2017 | 220% |
Axogen (AXGN) | 2017 | 210.99% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
